| Dr James J Murphy, MD | |
|
920 Oliver Rd # L, Monroe, LA 71201-5702 | |
| (318) 807-4713 | |
| (318) 807-1833 |
| Full Name | Dr James J Murphy |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 26 Years |
| Location | 920 Oliver Rd # L, Monroe, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336183854 | NPI | - | NPPES |
| 1555908 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01061032A (Indiana) | Secondary |
| 207XX0004X | Orthopaedic Surgery - Foot And Ankle Surgery | 036108372 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Heart Of Mary Medical Center | Urbana, IL | Hospital |
| Osf Sacred Heart Medical Center | Danville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
Now on Kaiser Health News' blog, Mary Agnes Carey reports: "Hospitals have come out swinging against payment cuts to their industry included in the House Republican plan to stop a scheduled Medicare physician payment cut next January. And the House GOP is swinging right back."
A new book by an Indonesian Health Minister has accused the United States and the World Health Organisation (WHO) of trying to profit from the spread of bird flu.
Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).
› Verified 4 days ago
| Entity Name | Southern Orthopedic Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396792412 PECOS PAC ID: 8921095514 Enrollment ID: O20040427000442 |
News Archive
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
Now on Kaiser Health News' blog, Mary Agnes Carey reports: "Hospitals have come out swinging against payment cuts to their industry included in the House Republican plan to stop a scheduled Medicare physician payment cut next January. And the House GOP is swinging right back."
A new book by an Indonesian Health Minister has accused the United States and the World Health Organisation (WHO) of trying to profit from the spread of bird flu.
Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).
› Verified 4 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
Now on Kaiser Health News' blog, Mary Agnes Carey reports: "Hospitals have come out swinging against payment cuts to their industry included in the House Republican plan to stop a scheduled Medicare physician payment cut next January. And the House GOP is swinging right back."
A new book by an Indonesian Health Minister has accused the United States and the World Health Organisation (WHO) of trying to profit from the spread of bird flu.
Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James J Murphy, MD 130 Desiard St Ste 355, Monroe, LA 71201-7363 Ph: (318) 807-7875 | Dr James J Murphy, MD 920 Oliver Rd # L, Monroe, LA 71201-5702 Ph: (318) 807-4713 |
News Archive
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
Now on Kaiser Health News' blog, Mary Agnes Carey reports: "Hospitals have come out swinging against payment cuts to their industry included in the House Republican plan to stop a scheduled Medicare physician payment cut next January. And the House GOP is swinging right back."
A new book by an Indonesian Health Minister has accused the United States and the World Health Organisation (WHO) of trying to profit from the spread of bird flu.
Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).
› Verified 4 days ago
Dr. White Solomon Graves Iv, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 | |
Kevin Jeffrey Bunn, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Oliver Rd, Monroe, LA 71201 Phone: 318-807-4713 Fax: 318-807-1833 | |
Dr. Sidney L Bailey, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 | |
Dr. Grant Arthur Dona, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 | |
Timothy Davenport Spires Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 | |
Dr. Scott K Mcclelland, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1501 Louisville Ave, Monroe, LA 71201 Phone: 318-323-8451 Fax: 318-361-2613 |